J&J Unit Slapped With $4M Verdict Over Topamax Birth Defects
A Philadelphia jury on Wednesday hit Janssen Pharmaceuticals Inc. with a $4 million verdict in a lawsuit that alleged its epilepsy drug Topamax caused birth defects....To view the full article, register now.
Already a subscriber? Click here to view full article